These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 11747904)
1. The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Al-Hayani A; Wease KN; Ross RA; Pertwee RG; Davies SN Neuropharmacology; 2001 Dec; 41(8):1000-5. PubMed ID: 11747904 [TBL] [Abstract][Full Text] [Related]
2. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Malinowska B; Kwolek G; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):562-9. PubMed ID: 11770012 [TBL] [Abstract][Full Text] [Related]
3. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. Di Marzo V; Lastres-Becker I; Bisogno T; De Petrocellis L; Milone A; Davis JB; Fernandez-Ruiz JJ Eur J Pharmacol; 2001 May; 420(2-3):123-31. PubMed ID: 11408034 [TBL] [Abstract][Full Text] [Related]
4. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Zygmunt PM; Petersson J; Andersson DA; Chuang H; Sørgård M; Di Marzo V; Julius D; Högestätt ED Nature; 1999 Jul; 400(6743):452-7. PubMed ID: 10440374 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro. Lees G; Dougalis A Brain Res; 2004 Jan; 997(1):1-14. PubMed ID: 14715144 [TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1). McVey DC; Schmid PC; Schmid HH; Vigna SR J Pharmacol Exp Ther; 2003 Feb; 304(2):713-22. PubMed ID: 12538826 [TBL] [Abstract][Full Text] [Related]
7. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899 [TBL] [Abstract][Full Text] [Related]
8. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors. Jerman JC; Gray J; Brough SJ; Ooi L; Owen D; Davis JB; Smart D Br J Anaesth; 2002 Dec; 89(6):882-7. PubMed ID: 12453933 [TBL] [Abstract][Full Text] [Related]
9. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid. Fowler CJ; Jonsson KO; Andersson A; Juntunen J; Järvinen T; Vandevoorde S; Lambert DM; Jerman JC; Smart D Biochem Pharmacol; 2003 Sep; 66(5):757-67. PubMed ID: 12948856 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. Andersson DA; Adner M; Högestätt ED; Zygmunt PM Mol Pharmacol; 2002 Sep; 62(3):705-13. PubMed ID: 12181448 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. White R; Ho WS; Bottrill FE; Ford WR; Hiley CR Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334 [TBL] [Abstract][Full Text] [Related]
13. Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence. de Lago E; de Miguel R; Lastres-Becker I; Ramos JA; Fernández-Ruiz J Brain Res; 2004 May; 1007(1-2):152-9. PubMed ID: 15064146 [TBL] [Abstract][Full Text] [Related]
14. The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro. Jennings EA; Vaughan CW; Roberts LA; Christie MJ J Physiol; 2003 Apr; 548(Pt 1):121-9. PubMed ID: 12562891 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. Veldhuis WB; van der Stelt M; Wadman MW; van Zadelhoff G; Maccarrone M; Fezza F; Veldink GA; Vliegenthart JF; Bär PR; Nicolay K; Di Marzo V J Neurosci; 2003 May; 23(10):4127-33. PubMed ID: 12764100 [TBL] [Abstract][Full Text] [Related]
16. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors. Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105 [TBL] [Abstract][Full Text] [Related]
17. A second endogenous cannabinoid that modulates long-term potentiation. Stella N; Schweitzer P; Piomelli D Nature; 1997 Aug; 388(6644):773-8. PubMed ID: 9285589 [TBL] [Abstract][Full Text] [Related]
18. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. De Petrocellis L; Bisogno T; Maccarrone M; Davis JB; Finazzi-Agro A; Di Marzo V J Biol Chem; 2001 Apr; 276(16):12856-63. PubMed ID: 11278420 [TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoid activation of recombinant and endogenous vanilloid receptors. Ralevic V; Kendall DA; Jerman JC; Middlemiss DN; Smart D Eur J Pharmacol; 2001 Jul; 424(3):211-9. PubMed ID: 11672565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]